241 related articles for article (PubMed ID: 27716394)
1. Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.
Konnick EQ; Pritchard CC
Genome Med; 2016 Oct; 8(1):100. PubMed ID: 27716394
[TBL] [Abstract][Full Text] [Related]
2. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
[TBL] [Abstract][Full Text] [Related]
3. A Case-Based Approach to Understanding Complex Genetic Information in an Evolving Landscape.
DiNardo CD; Korde LA; Yurgelun MB
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-11. PubMed ID: 34010053
[TBL] [Abstract][Full Text] [Related]
4. The current state of clinical interpretation of sequence variants.
Hoskinson DC; Dubuc AM; Mason-Suares H
Curr Opin Genet Dev; 2017 Feb; 42():33-39. PubMed ID: 28157586
[TBL] [Abstract][Full Text] [Related]
5. The Value of Parental Testing by Next-Generation Sequencing Includes the Detection of Germline Mosaicism.
Brewer CJ; Gillespie M; Fierro J; Scaringe WA; Li JM; Lee CY; Yen HY; Gao H; Strom SP
J Mol Diagn; 2020 May; 22(5):670-678. PubMed ID: 32092540
[TBL] [Abstract][Full Text] [Related]
6. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
[TBL] [Abstract][Full Text] [Related]
7. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
Mandelker D
Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
[TBL] [Abstract][Full Text] [Related]
8. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
[TBL] [Abstract][Full Text] [Related]
9. Tumor-only sequencing for oncology management: Germline-focused analysis and implications.
George A; Turnbull C
Genes Chromosomes Cancer; 2021 May; 60(5):352-357. PubMed ID: 33222309
[TBL] [Abstract][Full Text] [Related]
10. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
[TBL] [Abstract][Full Text] [Related]
11. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.
Kuhlen M; Borkhardt A
Eur J Pediatr; 2015 Aug; 174(8):987-97. PubMed ID: 25982339
[TBL] [Abstract][Full Text] [Related]
12. The impact of hereditary cancer gene panels on clinical care and lessons learned.
Okur V; Chung WK
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162654
[TBL] [Abstract][Full Text] [Related]
13. Computational methods and resources for the interpretation of genomic variants in cancer.
Tian R; Basu MK; Capriotti E
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S7. PubMed ID: 26111056
[TBL] [Abstract][Full Text] [Related]
14. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
Walsh MF; Ritter DI; Kesserwan C; Sonkin D; Chakravarty D; Chao E; Ghosh R; Kemel Y; Wu G; Lee K; Kulkarni S; Hedges D; Mandelker D; Ceyhan-Birsoy O; Luo M; Drazer M; Zhang L; Offit K; Plon SE
Hum Mutat; 2018 Nov; 39(11):1542-1552. PubMed ID: 30311369
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation panels: Time to clear their names.
Trottier AM; Cavalcante de Andrade Silva M; Li Z; Godley LA
Cancer Genet; 2019 Jun; 235-236():84-92. PubMed ID: 31101556
[TBL] [Abstract][Full Text] [Related]
16. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
Knapp E
J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
[No Abstract] [Full Text] [Related]
17. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
18. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
Mandelker D; Donoghue M; Talukdar S; Bandlamudi C; Srinivasan P; Vivek M; Jezdic S; Hanson H; Snape K; Kulkarni A; Hawkes L; Douillard JY; Wallace SE; Rial-Sebbag E; Meric-Bersntam F; George A; Chubb D; Loveday C; Ladanyi M; Berger MF; Taylor BS; Turnbull C
Ann Oncol; 2019 Aug; 30(8):1221-1231. PubMed ID: 31050713
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
McNulty SN; Parikh BA; Duncavage EJ; Heusel JW; Pfeifer JD
J Mol Diagn; 2019 Sep; 21(5):903-912. PubMed ID: 31251990
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
